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Natural Rubber Latex (NRL) can be used successfully in controlled release drug delivery due to their excellent 
matrix forming properties. Recently, NRL has shown to stimulate angiogenesis, cellular adhesion and the formation 
of extracellular matrix, promoting the replacement and regeneration of tissue. A dermatological delivery system 
comprising a topically acceptable, inert support impregnated with a metronidazole (MET) solution was developed. 
MET 2-(2- methyl- 5-nitro- 1H- imidazol- 1-yl) ethanol, has been widely used for the treatment of protozoa and 
anaerobic bacterial infections. MET is a nitroimidazole anti-infective medication used mainly in the treatment of 
infections caused by susceptible organisms, particularly anaerobic bacteria and protozoa. In a previous study, we 
have tested NRL as an occlusive membrane for GBR with promising results. One possible way to decrease the 
inflammatory process, it was incorporated the MET in NRL. MET was incorporated into the NRL, by mixing it in 
solution for in vitro protein delivery experiments. The solutions of latex and MET were polymerized at different 
temperatures, from –100 to 40 °C, in order to control the membrane morphology. SEM microscopy analysis 
showed that the number, size and distribution of pores in NRL membranes varied depending on polymerization 
temperature, as well as its overall morphology. Results demonstrated that the best drug-delivery system was the 
membrane polymerized at –100 °C, which does release 77,1% of its MET content for up 310 hours. 
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1. Introduction
Metronidazole 2-(2- methyl- 5-nitro- 1H- imidazol- 1-yl) ethanol 
is a cytostatic drug effective for treatment of rosacea, a common 
chronic syndrome characterized by persistent facial erythema, flush-
ing, edema, pustules, and papules1-2. It is available in gel formulation 
for the treatment of bacterial vaginosis as well as in topical gel and 
cream for the treatment of inflammatory lesions and erythema of 
rosacea3-5. Metronidazole (MET) is very effective for treatment of 
rosacea not only after systemic administration but also after topical 
application. To our knowledge, none of these methods have been 
validated for the release of MET in dermatological formulations. 
We reported here a novel sustained delivery system for MET 
based on Natural Rubber Latex (NRL). NRL membrane from Hevea 
brasiliensis has interesting characteristics related to this work such 
as: it is easy to manipulate, low cost, can stimulate the natural ang-
iogenesis, is a biocompatible material and presents high mechanical 
resistance. In according to literature, it is well known that NRL can 
give allergic reactions and has cytoxicity problems, which is of great 
concern especially on these new applications where NRL is used 
inside the human body6-8. However recently, several new biomedical 
applications for NRL have been proposed using a different manu-
facturing process (NRLb)9-12. Thus NRLb is processed avoiding the 
use of chemicals such as carbamates and sulphur, as well as does not 
suffer any heat treatments. Apparently this way of producing NRLb 
produces a much better biocompatible material13-16. In fact, NRLb is 
now commercialized in Brazil and other 60 countries as a band-aid 
curative (BIOCURE®) for the treatment of ulcers in diabetic patients 
among other applications17. 
In a previous study, NRb was tested as an occlusive membrane 
for Guided Bone Regeneration (GBR)18. The membrane was used 
in a critical defect in the rabbit calvaria, and did help healing the 
wound. In principle, NRL worked as a passive barrier membrane that 
prevented epithelial and connective tissue migration, thus facilitating 
the proliferation and migration of regenerative cells, such as oste-
oblasts, into the protected wound. One possible way to decrease the 
inflammatory process, it was incorporated the MET in NRL. MET 
was incorporated into the NRLb, by mixing it in solution for in vitro 
protein delivery experiments. 
Thus the ideal membrane would have to release MET along 
many weeks. So in this work different polymerization conditions 
were used in order to control the MET release of NRLb. NRLb po-
lymerized under different conditions, and with the incorporation of 
MET was characterized by Scanning Electron Microscopy (SEM), 
while membrane release of MET was characterized by the UV-VIS 
method. Results show that the NRLb membrane can release MET 
for up to 310 hours.
2. Experimental Procedures
Metronidazole 2-(2- methyl- 5-nitro- 1H- imidazol- 1-yl) ethanol 
was purchased from BIOFLORA Pharmaceutical Ltd., Brazil. The 
latex solution extracted from Hevea brasiliensis consisted in a mixture 
of different clones. The extraction was made in ESALQ-USP, Piraci-
caba, Brazil. After extraction, ammonia was used to keep the latex 
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liquid, and this material was centrifuged at 8000 g. The centrifugation 
was employed to reduce the protein content of NRLb 15.
In this work, membranes with 2 mL of natural rubber + 1 mL of 
metronidazole solution (10 mg.mL–1) were produced. These mem-
branes were prepared by pouring the latex+MET (NRLbMET) solu-
tion in a stainless steel plate with 5.00 ± 0.05 cm diameter, and left at 
different temperatures for polymerization: –100, –10, 27 °C (Room 
Temperture) and 40 °C during 2 hours. The temperatures chosen are 
known to change the porosity of the membranes19-21. After this, the 
solution was left in air for 2 day to complete the polymerization proc-
ess resulting in an elastic membrane. Finally, the NRLb membrane 
is sterilized using ethylene oxide. 
For the drug release study NRLbMET membranes were placed 
in 200 mL of aqueous solution, where the release behavior was 
observed. Aliquots of this solution were collected during an interval 
ranging from 10 to 24,000 minutes. The MET release as a function 
of time was determined using the UV-VIS method. The morphol-
ogy of membrane surface was observed using a Scanning Electron 
Microscocopy (SEM) model Zeiss® EVO 50 (15 KV) and X-ray 
diffraction and Energy Dispersive X-ray spectroscopy (EDS-SEM) 
with take off angle of 35°.
3. Results 
According to Herculano et al.21, Thermally Induced Phase 
Separation (TIPS) is a method to make microporous membrane22-24. 
This procedure is perhaps the most versatile and simplest membrane 
preparation technique. In this work, NRLb membranes were prepared 
in four different polymerization temperatures: –100, –10, 27 °C 
(RT) and 40 °C. Figure 1 shows typical SEM images of membranes 
polymerized at different temperatures. As can be seen, the pore sizes 
and density vary with polymerization temperature. NRLb polymerized 
at –100 °C (Figure 1a), –10 °C (Figure 1b) and RT (Figure 1c) have 
pores, while those membranes polymerized at RT 40 °C almost do 
not have. The density of pores is higher as the polymerization tem-
perature diminishes. Pore sizes with diameters ranging from 0.49 to 
5.12 μm were observed on the NRLb+MET membrane polymerized 
at –100 °C (Figure 1a), while the membrane polymerized at –10 °C 
displayed pore sizes of dimensions from 1.17 to 3.16 μm (Figure 1b) 
and membrane polymerized at RT displayed pores size of similar 
dimensions (1.03 ± 0.28) μm (Figure 1c).
In Figure 2 shows the absorbance intensity as a function of 
MET concentration in solution. This calibration curve is important 
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Figure 1. SEM images (magnification: × 10,000) of NRLb membranes with 
MET: a) Polymerized at –100 °C, (b) Polymerized at –10 °C, c) Polymerized at 
RT and d) Polymerized at 40 °C. Notice the difference in the pores density.
Figure 2. Absorbance intensity as a function of MET concentration in solu-
tion. The insert graph shows a typical spectrum of MET.
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in a colloidal state, in order to create a membrane that works as a 
delivery system. 
Several procedures are used to control the release of substances 
by polymers. For example Woo et al.26 used a combination of 3 dif-
ferent biodegradable microspheres of poly(D,L,-lactide-co-glycolide 
(PLGA)), using different molecular weight and terminal endings 
of the polymeric chain (hydrophilic or hydrophobic) to determine 
the best delivery system of BMP. They conclude that the best bone 
because to make one relationship between absorbance and the MET 
concentration. For this experiment several MET concentrations from 
0.3 to 33 μg.mL–1 were made. After this, it was measurement your 
absorbance. Using a calibration curve, an unknown concentration can 
be derived from a sample by measuring it’s response and then finding 
the corresponding y-axis intercept. Note that the insert graph shows a 
typical spectrum of MET. The MET solution absorbs at 330 nm. 
In Figure 3 MET release as a function of time is presented for 
membranes polymerized in similar conditions to the ones presented 
in Figure 1. The release from the membrane polymerized at –100 °C 
is higher than other membranes. The membrane polymerized at –1 °C 
not is presented because your pore density and consequently MET 
release rate is similar than membrane polymerized at –10 °C. The 
4 membranes reach saturation at different concentrations. In other 
words, the total amount of MET released by the membrane depends 
on the latex polymerization temperature. The uncertainties of MET re-
lease as a function of time (Figure 3) measurements were of 2-5%.
The experimental data in Figure 3 were fitted using a bi-exponen-
tial function y(t) = y0 +A1e–t/τ1 + A2e-t/τ2, where y(t) was the amount of 
MET in the NRL at a given time, t, y0 is the initial content of MET, 
A1 and A2 are constants and the are τ1 and τ2 are characteristic times. 
The Table 1 show the constants A1 and A2, and the characteristic times 
τ1 and τ2 of the natural rubber membranes polymerized at different 
temperatures. 
After integration of these curves until 310 hours, the total amount 
of MET released by the three membranes in 200 mL aqueous solution 
were: 15.41 mg (77.1% of the MET used in the starting material) 
for membrane polymerized at –100 °C and 11.86 mg (59.00%) for 
–10 °C, 10.63 mg (53.15%) for RT and 9.40 mg (47.02%) for 40 °C 
membranes respectively. 
4. Discussion
In this work, it was used the method proposed by Langer & 
 Folkman25, that is, to mix the protein (MET) with the polymer (latex) 
Figure 3. MET release as a function of time for NRL membrane prepared at 
different temperatures: 100 °C, –10 °C, RT and 40 °C. 
Table 1. A1 and A2 are constants and the τ1 and τ2 are characteristic times of the NRLb membranes prepared at different polymerization temperatures: –100, 
–10, 27 (RT) and 40 °C.
Natural rubber membranes A1 A2 τ1 τ2
Polymerized at –100 °C –2.199 –3.559 0.655 24.766
Polymerized at –10 °C –1.610 –0.816 29.941 3.581
Polymerized at RT –1.210 –0.699 2.788 58.066
Polymerized at 40 °C –0.359 –1.095 0.062 19.340
Figure 4. SEM-EDS spectra of: a) Metronidazole powder, c) and e) Natural Rub-
ber membrane + Metronidazole. Notice that the MET is present on surface.
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healing results were achieved using high dose and slow delivery rate 
systems. They used animal models in their study.
In this work, as already mentioned different polymerization tem-
perature was used in order to control the MET release rate. The SEM 
images (Figure 1) shows that polymerization temperature determines 
the morphology of the surface, producing pores and controlling the 
pores density. The pores density for membranes polymerized at –100, 
–10 °C are higher compared at RT and 40 °C. Almost no pores were 
observed in membranes polymerized at 40 °C. 
The release profile for MET in a NRL matrix in Figure 3 shows 
that the first, fast step of burst release corresponded to the MET 
near or on the surface of the NRL membrane. The slower release 
process would be associated with MET diffusing slowly through the 
matrix. Thus, the drug is not found in the more inner portion of the 
polymeric matrix, as can be inferred from Figure 4. Thus the MET 
release depends mainly on the amount of encapsulated material on 
surface (as a reservoir) and not on diffusion.
The release rate was also affected by temperature (Figure 3). 
It was observed that the NRL membrane polymerized at –100 °C 
presented the highest MET release. These results are in good agree-
ment with those by Wang et al.27. They used different amounts of 
glutaraldehyde in chitosan synthesis in micro sphere form to obtain 
different cross-linking degrees, and monitored its effect on BSA 
release. They found that as cross-linking increases the release rate 
becames slower. 
Notice that the molecule release after 310 hours, was 77.1% of 
the MET initially incorporated in the membrane polymerized at the 
–100 °C, 59.00% for the membrane polymerized at –10 °C, 53.15% 
for the membrane polymerized at RT and 47.02% for the membrane 
polymerized at 40 °C. 
As mentioned earlier the controlled release of proteins is of inter-
est for medical applications, since the dose can be adjusted according 
to the application envisaged. Our results indicate that with very simple 
changes in NRL preparation it is possible to control MET release up 
to 15 days, thus making them promising materials for protein release 
in in vivo applications. 
All sample of NRL aggregate with MET, has the best potential 
for MET release, according to the Woo et al.26 results. It was shown 
that these membranes delivered the incorporated MET in 310 hours, 
or in other words with a slow release rate.
5. Conclusion
The sustained delivery system for MET has been successfully 
developed based on NRLb. The rate release of MET was controlled 
varying the polymerization temperature of the latex matrix. It was 
shown that polymerization temperature determines the morphology 
of the surface, producing pores and controlling the pores density. 
Results indicate that with very simple changes in NRLb preparation 
it is possible to control MET release up to 310 hours, thus making 
them promising materials for protein release in in vivo applications. 
Particularly the NRLb polymerized at –100 °C has the best potential 
for MET release. For this membrane 77.1% of the initial MET content 
inside NRL was released in 310 hours, or in other words with a slow 
release rate. The SEM-EDS and the release behavior indicated that 
MET remains close or on the surface of the membrane. The drug is 
not found in the inner portion of the membrane. 
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